- Home
- CODI vs IMRX Comparison
CODI vs IMRX Comparison
Compare CODI & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CODI | IMRX |
|---|---|---|
| Founded | 2005 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.2M | 366.1M |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CODI | IMRX |
|---|---|---|
| Price | $6.47 | $4.93 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $13.00 | ★ $17.20 |
| AVG Volume (30 Days) | ★ 1.3M | 1.2M |
| Earning Date | 02-25-2026 | 03-19-2026 |
| Dividend Yield | ★ 3.91% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,898,956,000.00 | N/A |
| Revenue This Year | $5.09 | N/A |
| Revenue Next Year | $1.65 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.27 | N/A |
| 52 Week Low | $4.58 | $1.10 |
| 52 Week High | $22.21 | $10.08 |
Technical Indicators
Market Signals| Indicator | CODI | IMRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.88 | 47.13 |
| Support Level | $6.14 | $4.86 |
| Resistance Level | $7.24 | $5.15 |
| Average True Range (ATR) | 0.48 | 0.31 |
| MACD | -0.04 | 0.07 |
| Stochastic Oscillator | 6.36 | 60.98 |
Price Performance
Historical ComparisonAbout CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.